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The idiopathic inflammatory myopathies (IIMs) are char-
acterized by muscle weakness, electromyography (EMG),
histological and biochemical features of muscle inflam-
mation. Their classification is evolving due to the myosi-
tis-associated autoantibody panel. Anti-aminoacyl-tRNA
synthetase (ARS) antibodies are detected in 25-30%
patients and define the anti-synthetase syndrome (ASS),
a spectrum of interstitial lung disease (ILD), arthritis,
fever, Raynaud’s phenomenon and mechanic’s hands.
Anti-Jo1 antibodies are most common (20%), whereas
anti-PL12 antibodies (alanyl-tRNA synthetase) occur in
<3% cases.
We report a 58-year-old male with IIM associated
with anti-PL12 antibodies, who presented with a three-
week history of severe widespread muscle pain, without
overt muscle weakness. He also reported polyarthralgia,
exertional dyspnoea, dry cough and weight loss. Exami-
nation revealed low-grade pyrexia, bi-basal crepitations
and exquisitely tender muscles. Notably, there was no
proximal muscle weakness or neurological deficit.
Investigations revealed marked acute phase response
(CRP 121 mg/l, ESR 79 mm/hr), polyclonal hypergamma-
globulinaemia and raised ALT 276 U/l (0-40). Serology
demonstrated high-titre anti-nuclear antibodies (1:1280,
speckled). Serum Western blotting revealed anti-PL12
antibodies. No other autoantibodies were detected. Crea-
tinine kinase was elevated 936 U/l (0-200), EMG was
consistent with myositis. MRI thighs demonstrated high
signal within the semitendinosis muscle.
Muscle histology confirmed a florid inflammatory myo-
pathy with disruption, oedema and considerable macro-
phage and lymphocytic infiltrate of perimysial connective
tissue – typical features of ASS. Spirometry was restrictive
with reduced corrected gas transfer. CT chest showed
non-specific interstitial pneumonia.
Prednisolone 60mg daily, resulted in improvement of
dyspnoea and normalisation of CRP and CK.
Significant muscle pain (requiring morphine) was
steroid-responsive, but only to high doses, with recur-
rence on dose reduction. Pulsed cyclophosphamide was
commenced, with improvement in muscle pain after
the first dose.
Severe muscular pain and tenderness in the absence of
weakness, is atypical of ASS and has not been previously
reported. Anti-PL12 antibodies are rare, therefore their
associated clinical features are not well-described, unlike
the Jo-1 syndrome. ILD is common, usually precedes
muscle involvement and may occur in isolation. Previous
reports suggest that muscle involvement is uncommon
and mild (often subclinical). Further reports and prospec-
tive studies will help refine the clinical phenotype of anti-
PL12 antibody-positive ASS subtype.
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